MedPath

ncontrolled trial of Rituximab treatment on refractory or steroid dependent nephrotic syndrome in adult.

Not Applicable
Conditions
refractory or steroid dependent nephrotic syndrome
Registration Number
JPRN-UMIN000014355
Lead Sponsor
Saitama Medical University Department of Nephrology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

Positive serology for hepatitis B, Cardiac failure, Lung dysfunction, Bone marrow dysfunction, Pregnant subjects or subjects who do not agree with contraception during the study period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Remission rate Relapse rate The cumulative dose of prednisolone and immunosuppressive drug
Secondary Outcome Measures
NameTimeMethod
The adverse effect of prednisolone. The adverse effect of immunosuppressive drug The adverse effect of rituximab
© Copyright 2025. All Rights Reserved by MedPath